Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essenti...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | Englisch |
| Veröffentlicht: |
Cham :
Springer International Publishing,
2018.
|
| Ausgabe: | 1st ed. 2018. |
| Schriftenreihe: | Resistance to Targeted Anti-Cancer Therapeutics,
15 |
| Schlagworte: | |
| ISBN: | 9783319679327 |
| ISSN: | 2196-5501 ; |
| Online-Zugang: |
|
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. |
|---|---|
| Beschreibung: | Biomedical and Life Sciences |
| Beschreibung: | XX, 242 p. 22 illus. in color. online resource. |
| ISBN: | 9783319679327 |
| ISSN: | 2196-5501 ; |